about
Nanomedicine-Mediated Therapies to Target Breast Cancer Stem CellsA mathematical model of cancer stem cell driven tumor initiation: implications of niche size and loss of homeostatic regulatory mechanismsA class of extracellular vesicles from breast cancer cells activates VEGF receptors and tumour angiogenesis.Cancer stem cell marker Musashi-1 rs2522137 genotype is associated with an increased risk of lung cancer.Clinically relevant doses of chemotherapy agents reversibly block formation of glioblastoma neurospheres.Breast cancer stem cells: Multiple capacities in tumor metastasis.Increased expression of DNA repair genes in invasive human pancreatic cancer cells.Tumor dormancy and the role of metastasis suppressor genes in regulating ectopic growth.Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics.HER2-associated radioresistance of breast cancer stem cells isolated from HER2-negative breast cancer cells.Cancer stem cells as mediators of treatment resistance in brain tumors: status and controversies.Strategies for isolating and enriching cancer stem cells: well begun is half doneStemming cancer: functional genomics of cancer stem cells in solid tumors.Epigenetic gene regulation in stem cells and correlation to cancerThe critical role of SDF-1/CXCR4 axis in cancer and cancer stem cells metastasis.No small matter: microRNAs - key regulators of cancer stem cells.Polymorphisms of the stem cell marker gene CD133 are associated the clinical outcome in a cohort of Chinese non-small cell lung cancer patients.
P2860
Q28066297-EA54213C-9A0D-4D41-B137-675015231E0FQ28535440-2EF6823B-F5E7-444E-A0BF-F25181B96DF1Q30839218-41EA2BBA-01E3-4137-A740-412EAC6517AEQ33560334-21E0FC2B-021D-435C-9749-53702514408EQ34037067-21F9EABD-E88C-4445-8FFE-D14FA6F83525Q34257303-66C046BC-9773-4F87-99DA-87AC9A8C9F4FQ35048189-CE31976D-0AAB-4492-8731-DB84234C387BQ36616513-772DDD6B-E254-496B-B34D-C45DC91FE1EAQ36643063-62774A96-CC2B-488E-BC00-65F099AAC873Q36670686-0F9CE2F3-B66D-476C-B4B9-2AF041F063F3Q37009796-C3BAA89F-110D-42F3-93D1-8A5C57C2A83BQ37061915-D7FF2CD8-36E4-4921-A59A-3D767DD6EAA0Q37193824-BEB4A2A9-B37D-46EC-8A24-32184A9FC356Q37251747-0C2DE791-5E9E-4310-9302-3315DD6CE3DBQ37321944-6AA0056B-6589-4F54-A1C8-65DAA800309EQ39868687-C7E271C9-EAE7-4CD7-B6DC-E15A89AC2B1BQ47112528-6E43C9F4-66AE-47F5-8853-56A5EB8D3C54
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
A self-renewal assay for cancer stem cells.
@ast
A self-renewal assay for cancer stem cells.
@en
type
label
A self-renewal assay for cancer stem cells.
@ast
A self-renewal assay for cancer stem cells.
@en
prefLabel
A self-renewal assay for cancer stem cells.
@ast
A self-renewal assay for cancer stem cells.
@en
P1476
A self-renewal assay for cancer stem cells.
@en
P2093
Michael F Clarke
P2860
P2888
P356
10.1007/S00280-005-0097-1
P478
56 Suppl 1
P577
2005-11-01T00:00:00Z